US SB1961 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on June 13 2023 - 25% progression
Action: 2023-06-13 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 13 2023 - 25% progression
Action: 2023-06-13 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require an interagency risk assessment of the pharmaceutical supply chain to identify and mitigate health and national security risks, and for other purposes.
Title
Pharmaceutical Supply Chain Risk Assessment Act of 2023
Sponsors
Sen. Gary Peters [D-MI] | Sen. Joni Ernst [R-IA] |
History
Date | Chamber | Action |
---|---|---|
2023-06-13 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/senate-bill/1961/all-info |
Text | https://www.congress.gov/118/bills/s1961/BILLS-118s1961is.pdf |